25 May 2016

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final agenda

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Apologies – Part 1 only (open session)
  3. Any other business – Part 1 only (open session)
  4. Topic session – Appraisal of Bosutinib for previously treated chronic myeloid leukaemia (review of TA299)
    • 4.1. Declarations of interest – Part 1 only (open session)
    • 4.2. Introduction by Jane Adam – Part 1 only (open session)
    • 4.3. Presentation by Jane Adam and the lead team – Part 1 AND part 2 (open and closed session)
    • 4.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  5. Topic session – Appraisal Pemetrexed maintenance treatment following induction therapy with pemetrexed and cisplatin for non-squamous non-small-cell lung cancer (review of TA309)
    • 5.1. Declarations of interest – Part 1 only (open session)
    • 5.2. Introduction by Jane Adam – Part 1 only (open session)
    • 5.3. Presentation by Jane Adam and the lead team – Part 1 AND part 2 (open and closed session)
    • 5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

Date, time and venue of next meeting

Tuesday 26 July 2016, 10:00. Location TBC.

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is 11 May 2016. Please note that it may not be possible to accept late registration requests. 

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Jon Littler.

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk.Further information about conducting research is also available in our Common Questions and Answers about meetings in public document

 

Registration period: 26 April 2016 to 11 May 2016
Registration is closed.